Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation
Ameet Patel(Vanderbilt University Medical Center), Adetola A. Kassim(Vanderbilt University), Reena Jayani(Vanderbilt University Medical Center), Michael Byrne(Vanderbilt University Medical Center), James A. Connelly(Michigan Center for Translational Pathology), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Deva Sharma(University of Vermont), Carrie L. Kitko(Vanderbilt University Medical Center), Wichai Chinratanalab(VA Tennessee Valley Healthcare System), Katie S. Gatwood(Vanderbilt University Medical Center), Salyka Sengsayadeth(VA Tennessee Valley Healthcare System), Bipin N. Savani(Vanderbilt University Medical Center), Karina Wilkerson(Vanderbilt University Medical Center), Jennifer Green(Boston University), Heidi Chen(Vanderbilt University Medical Center)
Cited by 3
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435